HNB
ARIA

Huntington National Bank’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Huntington National Bank’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-400
Closed -$3K – 1816
2014
Q4 		$3K Buy
+400
New +$2.5K ﹤0.01% 1616
2014
Q1 		– Sell
-200
Closed -$1K – 1730
2013
Q4 		$1K Hold
200
– – ﹤0.01% 1696
2013
Q3 		$4K Sell
200
-1,000
-83% -$19.4K ﹤0.01% 1602
2013
Q2 		$20K Buy
+1,200
New +$21.3K ﹤0.01% 1297

Other funds holding ARIA

SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Huntington National Bank's ARIA Position: Q1 2015 in Review

Huntington National Bank sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2015, closing a stake of 400 shares — an estimated $3K sold.

Huntington National Bank first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $20K in Q2 2013. 193 funds tracked by Wall St. Rank hold ARIA as of Q1 2015.

  • Huntington National Bank reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2015 after selling out during the quarter.
  • Huntington National Bank sold 400 Ariad Pharmaceuticals Inc shares in Q1 2015, an estimated $3K.
  • Huntington National Bank first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Huntington National Bank's Ariad Pharmaceuticals Inc position peaked at $20K in Q2 2013.
  • 193 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2015.

Based on Huntington National Bank's 13F filing for Q1 2015, filed 28 Apr 2015.